Delivery Order SPE2DB24D2205-SPE2DB24FDVTA

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The single-award indefinite delivery contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical and is valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of AIMOVIG 140 MG/ML autoinjectors to the Defense Logistics Agency (DLA). The $7,244.57 firm fixed-price contract has a completion date of February 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,052.53 and is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTOR pharmaceuticals. The contract is not set aside and is a firm fixed price arrangement. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award is for the delivery of Aimovig 70 mg/ml autoinjectors to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a ceiling value of $2,199.04 and is a firm fixed-price delivery order, with an ultimate completion date of April 24, 2024. This award is not associated with a set-aside...
This federal contract award is for the delivery of Aimovig 70 mg/ml autoinjectors to the Defense Logistics Agency (DLA). The $2,603.83 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price contract, valued at $1,382.46, has a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,371.23 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024. The contract has a period of performance through June 26, 2024 and does not have any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,088.07 delivery order is under a larger, single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which expires on December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the medication Aimovig 140 mg/ml autoinjectors. The contract, valued at $11,976.58, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of the pharmaceutical product AIMOVIG 70 MG/ML AUTOINJECTORML. The contract, valued at $1,243.88, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has no set-aside designation and will run through April 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVTA
    Delivery Order

This federal contract award is for the pharmaceutical product Aimovig 140 mg/mL Autoinjector, awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/17/24, 9:49 AM